Target intelligence / Profile preview

U6 small nuclear RNA 276, pseudogene (RNU6-276P)

Target
RNU6-276P
Molecular classification
Other
01

Overview

**RNU6-276P** refers to a pseudogene member of the U6 small nuclear RNA family. U6 small nuclear RNAs (snRNAs) are critical non-coding RNA components of the spliceosome complex, which catalyzes the removal of introns from pre-mRNA—a key step in mRNA maturation in eukaryotes[1][2]. However, RNU6-276P is a pseudogene: it is a non-functional, typically non-expressed genomic sequence derived from the U6 snRNA gene, likely generated via retrotranspositional processes[3]. While the canonical U6 snRNA gene (for example, RNU6-1 in humans) is crucial for splicing, pseudogenes like RNU6-276P do not produce a functional RNA product and have no known role in splicing or other biological functions[1][2][3]. Pseudogenes are generally not considered therapeutic targets, do not interact with drugs or function as disease-relevant biomarkers, and have no established involvement in disease pathogenesis or patient safety[2][3]. **Additional context:** - **U6 small nuclear RNA** is highly conserved and essential for spliceosome function[1][2]. - **Pseudogenes** like RNU6-276P are frequent in the genome due to the evolutionary importance and high copy number of U6 snRNA genes in vertebrates[2][3]. **Key limitation:** The sequence RNU6-276P specifically specifies a pseudogene—a non-functional remnant of a U6 snRNA gene, not a receptor, enzyme, or therapeutic target. If you intend to refer to functional U6 snRNA, use "U6 small nuclear RNA" or "RNU6" (without pseudogene designation)[2][3].

Other names
RNA, U6 small nuclear 276, pseudogeneRNU6-276P

Beyond the preview

Go deeper on U6 small nuclear RNA 276, pseudogene (RNU6-276P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 276, pseudogene (RNU6-276P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call